223 related articles for article (PubMed ID: 24906794)
21. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
Gautschi F; Vogelmann T; Ortmanns G; Knörr F; Steinack C; Hage R; Nägeli M; Schuurmans MM
J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
Pecoraro Y; Carillo C; Diso D; Mantovani S; Cimino G; De Giacomo T; Troiani P; Shafii M; Gherzi L; Amore D; Rendina EA; Venuta F; Anile M
Transplant Proc; 2017 May; 49(4):695-698. PubMed ID: 28457374
[TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of lung-restricted antibodies in lung transplantation.
Akbarpour M; Wu Q; Liu X; Sun H; Lecuona E; Tomic R; Bhorade S; Mohanakumar T; Bharat A
Hum Immunol; 2019 Aug; 80(8):595-601. PubMed ID: 31078336
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 in a lung transplant recipient: Exploring the diagnostic role of circulating exosomes and the clinical impact of advanced immunosuppression.
Goodlet KJ; Bansal S; Arjuna A; Nailor MD; Buddhdev B; Abdelrazek H; Mohamed H; Omar A; Walia R; Mohanakumar T; Tokman S
Transpl Infect Dis; 2021 Apr; 23(2):e13480. PubMed ID: 32997881
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Off-Line Extracorporeal Photochemotherapy in Patients with Chronic Lung Allograft Rejection Not Responsive to Conventional Treatment: A 10-Year Single-Centre Analysis.
Del Fante C; Scudeller L; Oggionni T; Viarengo G; Cemmi F; Morosini M; Cascina A; Meloni F; Perotti C
Respiration; 2015; 90(2):118-28. PubMed ID: 26112178
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
Chionis L; Grossman BJ; Hachem R; Commean P; Derfler MC; Vedantham S; Dodds K; Spitznagel E; Atkinson J; Despotis G
Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
[TBL] [Abstract][Full Text] [Related]
27. Outcome of Extracorporeal Photopheresis as an Add-On Therapy for Antibody-Mediated Rejection in Lung Transplant Recipients.
Benazzo A; Worel N; Schwarz S; Just U; Nechay A; Lambers C; Böhmig G; Fischer G; Koren D; Muraközy G; Knobler R; Klepetko W; Hoetzenecker K; Jaksch P
Transfus Med Hemother; 2020 Jun; 47(3):205-213. PubMed ID: 32595425
[TBL] [Abstract][Full Text] [Related]
28. Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.
Greer M; Dierich M; De Wall C; Suhling H; Rademacher J; Welte T; Haverich A; Warnecke G; Ivanyi P; Buchholz S; Gottlieb J; Fuehner T
Am J Transplant; 2013 Apr; 13(4):911-918. PubMed ID: 23406373
[TBL] [Abstract][Full Text] [Related]
29. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
Jaksch P; Scheed A; Keplinger M; Ernst MB; Dani T; Just U; Nahavandi H; Klepetko W; Knobler R
J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
[TBL] [Abstract][Full Text] [Related]
30. A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.
Nath DS; Tiriveedhi V; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
Transplantation; 2011 May; 91(9):1036-43. PubMed ID: 21383658
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions.
Hefazi M; Langer KJ; Khera N; Adamski J; Roy V; Winters JL; Gastineau DA; Jacob EK; Kreuter JD; Gandhi MJ; Hogan WJ; Litzow MR; Hashmi SK; Yadav H; Iyer VN; Scott JP; Wylam ME; Cartin-Ceba R; Patnaik MM
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1906-1913. PubMed ID: 29679771
[TBL] [Abstract][Full Text] [Related]
32. Extracorporeal photopheresis for bronchiolitis obliterans syndrome after allogeneic stem cell transplant: An emerging therapeutic approach?
Del Fante C; Perotti C
Transfus Apher Sci; 2017 Feb; 56(1):17-19. PubMed ID: 28094112
[TBL] [Abstract][Full Text] [Related]
33. Initiation of extracorporeal photopheresis in lung transplant patients with mild to moderate refractory BOS: A single-center real-life experience.
Leroux J; Hirschi S; Essaydi A; Bohbot A; Degot T; Schuller A; Olland A; Kessler R; Renaud-Picard B
Respir Med Res; 2022 May; 81():100913. PubMed ID: 35525096
[TBL] [Abstract][Full Text] [Related]
34. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
[TBL] [Abstract][Full Text] [Related]
35. Lung transplantation and extracorporeal photopheresis: The answer to bronchiolitis obliterans?
Yung GL; Craig V
Transfus Apher Sci; 2015 Apr; 52(2):162-6. PubMed ID: 25881738
[TBL] [Abstract][Full Text] [Related]
36. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
Vazirani J; Routledge D; Snell GI; Watson D; Paraskeva M; Westall GP; Harrison SJ
Transplant Proc; 2021; 53(1):296-302. PubMed ID: 33039145
[TBL] [Abstract][Full Text] [Related]
37. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
Lobo LJ; Aris RM; Schmitz J; Neuringer IP
J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
[TBL] [Abstract][Full Text] [Related]
38. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
39. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation.
Hachem RR; Yusen RD; Meyers BF; Aloush AA; Mohanakumar T; Patterson GA; Trulock EP
J Heart Lung Transplant; 2010 Sep; 29(9):973-80. PubMed ID: 20558084
[TBL] [Abstract][Full Text] [Related]
40. Indication-specific immunomodulatory effects of extracorporeal photopheresis: A pilot study in heart transplanted patients.
Dieterlen MT; Garbade J; Misfeld M; Lehmann S; Klaeske K; Borger MA; Barten MJ
J Clin Apher; 2018 Oct; 33(5):591-599. PubMed ID: 30176056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
